# BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
> **ANDA219166** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2026-06-11
## Drug
- **FDA Application Number:** ANDA219166
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- **Generic name:** BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- **Active ingredients:** BRIMONIDINE TARTRATE; TIMOLOL MALEATE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Gland Pharma Limited
- **First approval:** 2026-06-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219166)
---
*MORVS · CC0 1.0*